Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBMM (Companhia Brasileira de Metalurgia e Mineração) is the global leader in the production and commercialization of Niobium products, with a significant and growing presence in the life sciences sector. Through its "Niobium in Health" initiative, the company focuses on the development of advanced Niobium-based alloys and bioactive materials for medical and dental applications. These materials are engineered to provide superior biocompatibility, high corrosion resistance, and improved osseointegration for orthopedic and dental implants. CBMM collaborates extensively with international research centers and medical device companies to innovate in areas such as 3D-printed implants and neurological devices. The company's materials science expertise aims to improve patient outcomes by increasing the durability and biological integration of permanent medical implants. As the supplier of the vast majority of the world's Niobium, CBMM is uniquely positioned to scale these technological advancements globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBMM.